|
|
Article: Aethlon Medical Reports 85-100 Percent Removal of HIV from Human Blood and Expands HIV-AIDS Treatment Pipeline.
- Article from:
- Business Wire
- Article date:
- September 10, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
BIOWIRE2K
LA JOLLA, Calif.--(BW HealthWire)--Sept. 10, 2001
Aethlon Medical (OTCBB:AEMD) announced today that pre-clinical human blood trials of the company's HIV-Hemopurifier(TM) have consistently documented a 55 percent removal of HIV from whole human blood in three hours and an 85-100 percent removal of HIV during the equivalent of one overnight treatment.
"This is a major milestone. Our device is actually performing better than originally expected," said Richard Tullis, Ph.D., chief science officer at Aethlon. "We are now one step closer in our efforts to initiate human trials and deliver ...